Medication info

AllonProtect Injection (Sodium Hyaluronate) (Pre-filled)

Prescription medicationInjection
Ingredient · strength
Sodium Hyaluronate›15mg / 1mL
Manufacturer / importer
IYON Pharmaceutical Co., Ltd.
Appearance
A colorless, transparent, and viscous liquid contained in a glass vial sealed with rubber stoppers (part of a pre-filled syringe system).
Packaging
0.85mL/vial
Approval status
Active

MFDS item code 201805278 · Notified 2018.12.26 · Insurance code 658603631

Summary

Main use
Adjunctive treatment in ophthalmic surgery (e.g., cataract surgery and corneal transplantation)
Who receives it
Adults
Adult administration
1. Cataract surgery and intraocular lens implantation Slowly inject the required amount of this medicine into the anterior chamber of the eye through a needle or cannula, before or after removal of the lens. To optimize its corneal endothelial protective effect as an adjunct, it should be injected before cataract extraction or intraocular lens implantation; therefore, inject it before intracapsular or extracapsular cataract surgery. This medicine may be used to coat surgical instruments and the intraocular lens to be implanted. 2. Corneal transplantation After removing the corneal graft, fill the anterior chamber with this medicine until it is level with the corneal surface. Place the donor graft on this medicine and suture it. 3. Glaucoma filtration surgery Inject this medicine through a corneal paracentesis to replenish and maintain the volume of the anterior chamber during trabeculectomy.

Ingredients

Manufacturer
IYON Pharmaceutical Co., Ltd.

Efficacy & effects

Adjunctive treatment in ophthalmic surgery (e.g., cataract surgery and corneal transplantation)

View approved original text

This medication is used adjunctively during various ophthalmic surgeries such as lens implantation in cataract surgery, corneal transplant surgery, and glaucoma surgery.

How it is given

Adult administration

1. Cataract surgery and intraocular lens implantation Slowly inject the required amount of this medicine into the anterior chamber of the eye through a needle or cannula, before or after removal of the lens. To optimize its corneal endothelial protective effect as an adjunct, it should be injected before cataract extraction or intraocular lens implantation; therefore, inject it before intracapsular or extracapsular cataract surgery. This medicine may be used to coat surgical instruments and the intraocular lens to be implanted. 2. Corneal transplantation After removing the corneal graft, fill the anterior chamber with this medicine until it is level with the corneal surface. Place the donor graft on this medicine and suture it. 3. Glaucoma filtration surgery Inject this medicine through a corneal paracentesis to replenish and maintain the volume of the anterior chamber during trabeculectomy.

Precautions

This medication is made of sodium hyaluronate and is primarily used during ophthalmic surgeries. It should not be administered to patients who have a history of allergy to this medication’s components or to any protein-based medication. After use, various side effects may appear in the eyes, such as increased intraocular pressure, inflammation, corneal edema, corneal opacity, and bleeding. Rarely, abnormalities in the iris or opacification of the lens may occur. In patients using intraocular lenses, there is a possibility of opacification on the surface of the lens. This product contains phosphates, which have been rarely reported to cause calcification of the cornea in patients with severe corneal damage. Particularly after surgery, it is essential to closely monitor the eye pressure; if the intraocular pressure rises, appropriate measures should be taken. After surgery, it is advisable to cleanse or aspirate this medication. When performing lens extraction surgery using ultrasound, it is necessary to inject irrigation fluid between this product and the lens to create space. When cleaning surgical instruments, solutions containing quaternary ammonium compounds such as benzalkonium chloride should not be used. Since this product is a substance isolated and purified from avian cells, be aware that there may be immunological reactions or other potential risks upon administration. Furthermore, it should not be used in conjunction with other medications containing hyaluronidase. This medication is only to be administered directly to the eye, and intravenous injection is strictly prohibited. Before use, it is recommended to allow the refrigerated medication to reach room temperature for approximately 30 minutes. Caution is needed as precipitates may form when in contact with components such as benzalkonium chloride or chlorhexidine. Once opened, it should be used only once, with any remaining solution disposed of in its container. When using this medication in conjunction with air, care must be taken to ensure that air does not enter the eye, especially beneath the iris. When injecting the medication, it should be administered slowly and carefully; excessive injection may lead to increased intraocular pressure after surgery, so avoid overdose. For storage, keep this medication out of reach of children and store it in a cool, dry place away from direct sunlight, in a sealed container. To maintain quality, do not transfer the medication to other containers and take care to prevent misuse.

Side effects

Increased intraocular pressure, inflammatory response, corneal edema, corneal opacity, anterior chamber hemorrhage, iris neovascularization, posterior iris ulcer, conjunctival adhesion failure, mydriasis, lens opacity, pain, pruritus, blurred vision, corneal dysfunction, opacification of intraocular lens surface, corneal calcification

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent contact with air, and kept in a cool place between 2 and 8 degrees Celsius. Furthermore, care should be taken to avoid direct sunlight and freezing to ensure safe usage.

Appearance and packaging

Appearance

A colorless, transparent, and viscous liquid contained in a glass vial sealed with rubber stoppers (part of a pre-filled syringe system).

Package unit

0.85mL/vial

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.